| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |